All references that do not fit into, or that stand apart from, the other management categories
List was last updated on
.-
- Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.
- Biskupiak J, Unni S, Telford C, Yoo M, Ye X, Deka R, Brixner D, Stenehjem D.
- BMC Health Serv Res. 2021 Jan 13;21(1):58. doi: 10.1186/s12913-020-06038-z.
- PMID: 33435985
- PubMed abstract
-
- Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.
- Cardoso F, MacNeill F, Penault-Llorca F, Eniu A, Sardanelli F, Nordström EB, Poortmans P.
- Breast. 2021 Jan 2;55:128-135. doi: 10.1016/j.breast.2020.12.010. Epub ahead of print.
- PMID: 33461060
- PubMed abstract
-
- Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
- Qin N, Wang Z, Liu Q, Song N, Wilson CL, Ehrhardt MJ, Shelton K, Easton J, Mulder H, Kennetz D, Edmonson MN, Rusch MC, Downing JR, Hudson MM, Nichols KE, Zhang J, Robison LL, Yasui Y.
- J Clin Oncol. 2020 Jun 4:JCO1902760. doi: 10.1200/JCO.19.02760. Epub ahead of print.
- PMID: 32496904
- PubMed abstract
- Source abstract
Research news: Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type. (GenomeWeb)
-
- Tissue-Specific Carcinogens as Soil to Seed BRCA1/2-Mutant Hereditary Cancers.
- Singh AK, Yu X.
- Trends Cancer. 2020 Apr 23. pii: S2405-8033(20)30105-9. doi: 10.1016/j.trecan.2020.03.004. [Epub ahead of print]
- PMID: 32336659
- PubMed abstract
- Source abstract
-
- Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control.
- Widschwendter M, Dubeau L.
- Cancers (Basel). 2020 Feb 27;12(3). pii: E547. doi: 10.3390/cancers12030547.
- PMID: 32120796
- PubMed abstract
- Source abstract
-
- Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers.
- Petelin L, Hossack L, Shanahan M, Mitchell G, Liew D, James PA, Trainer AH.
- Genet Med. 2020 Jan 30. doi: 10.1038/s41436-020-0751-3. [Epub ahead of print]
- PMID: 31996782
- PubMed abstract
- Source abstract
-
- Genetic Protection Modifications: Moving Beyond the Binary Distinction Between Therapy and Enhancement for Human Genome Editing.
- Mikkelsen RB, Frederiksen HRS, Gjerris M, Holst B, Hyttel P, Luo Y, Freude K, Sandøe P.
- CRISPR J. 2019 Dec;2(6):362-369. doi: 10.1089/crispr.2019.0024.
- PMID: 31860350
- PubMed abstract
- Source abstract
-
- Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.
- Ben-David MA, Corn BW, Evron E, Goldberg H, Pfeffer RM, Abdah-Bortnyak R, Matceyevsky D, Weinstein Y, Golan O, Sklair-Levy M.
- Breast. 2019 Nov 6;49:70-73. doi: 10.1016/j.breast.2019.10.011. [Epub ahead of print]
- PMID: 31734591
- PubMed abstract
-
- Salivary Gland Function, Antioxidant Defence and Oxidative Damage in the Saliva of Patients with Breast Cancer: Does the BRCA1 Mutation Disturb the Salivary Redox Profile?
- Sawczuk B, Maciejczyk M, Sawczuk-Siemieniuk M, Posmyk R, Zalewska A, Car H.
- Cancers (Basel). 2019 Oct 8;11(10). pii: E1501. doi: 10.3390/cancers11101501.
- PMID: 31597313
- PubMed abstract
- Source abstract
-
- Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy.
- Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Csorba R, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP.
- Eur J Med Res. 2019 Sep 14;24(1):32. doi: 10.1186/s40001-019-0391-8.
- PMID: 31521205
- PubMed abstract
-
- Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer.
- Zhu J, Tucker M, Marin D, Gupta RT, Healy P, Humeniuk M, Jarvis C, Zhang T, McNamara M, George DJ, Wu Y, Lisi S, Armstrong AJ.
- Urol Oncol. 2019 Jul 18. pii: S1078-1439(19)30244-3. doi: 10.1016/j.urolonc.2019.06.015. [Epub ahead of print]
- PMID: 31327751
- PubMed abstract
- Source abstract
-
- Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants.
- Sacca RE, Koeller DR, Rana HQ, Garber JE, Morganstern DE.
- J Genet Couns. 2019 Jun;28(3):708-716. doi: 10.1002/jgc4.1046. Epub 2019 Jan 24.
- PMID: 30680866
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
- Sandner AS, Weggel R, Mehraein Y, Schneider S, Hiddemann W, Spiekermann K.
- PLoS One. 2019 Apr 18;14(4):e0215453. doi: 10.1371/journal.pone.0215453. eCollection 2019.
- PMID: 30998723
- PubMed abstract
-
- Contralateral breast irradiation in BRCA carriers: the conundrum of prophylactic versus early treatment.
- Poortmans PMP, Kaidar-Person O.
- Ann Oncol. 2019 Mar 1;30(3):348-350. doi: 10.1093/annonc/mdz014.
- PMID: 30657851
- PubMed abstract
- Source abstract
-
- Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
- Evron E, Ben-David AM, Goldberg H, Fried G, Kaufman B, Catane R, Pfeffer MR, Geffen DB, Chernobelsky P, Karni T, Abdah-Bortnyak R, Rosengarten O, Matceyevsky D, Inbar M, Kuten A, Corn BW.
- Ann Oncol. 2019 Mar 1;30(3):412-417. doi: 10.1093/annonc/mdy515.
- PMID: 30475942
- PubMed abstract
- Source abstract
Editorial:
Is bilateral radiation an option for BRCA mutation carriers with unilateral breast cancer?
- PMID: 31168446
- PubMed abstract
- Free Full Text
-
- Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure.
- Sridharan DM, Enerio S, Wang C, LaBarge MA, Stampfer MR, Pluth JM.
- Life Sci Space Res (Amst). 2019 Feb;20:101-112. doi: 10.1016/j.lssr.2018.10.002. Epub 2018 Oct 21.
- PMID: 30797427
- PubMed abstract
-
- Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model.
- Hoskins P, Eccleston A, Hurry M, Dyer M.
- Gynecol Oncol. 2019 Jan 28. pii: S0090-8258(19)30061-7. doi: 10.1016/j.ygyno.2019.01.018. [Epub ahead of print]
- PMID: 30704745
- PubMed abstract
- Source abstract
-
- Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom.
- Autier P.
- JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6501. [Epub ahead of print]
- PMID: 30653221
- PubMed abstract
- Source abstract
Letter, Reply:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.
- PMID: 30653219
- PubMed abstract
- Source abstract
Original research:
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
- PMID: 29978189
- PubMed abstract
- Free Full Text
-
- [Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
- Amat L, Bulach A, Leclercq M, Mesrine S, Scheffler F, Sperandeo D, Scheffler M.
- Gynecol Obstet Fertil Senol. 2018 Dec;46(12):883-888. doi: 10.1016/j.gofs.2018.10.013. Epub 2018 Nov 7.
- PMID: 30414725
- PubMed abstract
- Source abstract
-
- Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
- Pashayan N, Morris S, Gilbert FJ, Pharoah PDP.
- JAMA Oncol. 2018 Nov 1;4(11):1504-1510. doi: 10.1001/jamaoncol.2018.1901.
- PMID: 29978189
- PubMed abstract
Editorial:
Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine.
- PMID: 29978191
- PubMed abstract
- Source abstract
Audio Interview: Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening. (JAMA Oncology)
Press: Breast Cancer Screening Only for Women at Higher Risk. (Medscape)
Letter, Comment:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom
Letter, Reply:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom—Reply.
-
- Breast cancer in transgender patients: A systematic review. Part 1: Male to female.
- Hartley RL, Stone JP, Temple-Oberle C.
- Eur J Surg Oncol. 2018 Oct;44(10):1455-1462. doi: 10.1016/j.ejso.2018.06.035. Epub 2018 Jul 25.
- PMID: 30087072
- PubMed abstract
- Source abstract
-
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
- Petelin L, Trainer AH, Mitchell G, Liew D, James PA.
- Genet Med. 2018 Oct;20(10):1145-1156. doi: 10.1038/gim.2017.255. Epub 2018 Jan 11.
- PMID: 29323669
- PubMed abstract
- Source abstract
-
- Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
- McVeigh TP, Wiggins J, Ward S, Kemp Z, George AJ.
- Clin Breast Cancer. 2018 Aug;18(4):282-288. doi: 10.1016/j.clbc.2017.10.015. Epub 2017 Oct 28.
- PMID: 29191429
- PubMed abstract
- Source abstract
-
- Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation.
- Wolf-Gould CS, Riley MR, Carswell JM.
- LGBT Health. 2018 May/Jun;5(4):221-225. doi: 10.1089/lgbt.2017.0149.
- PMID: 29870317
- PubMed abstract
- Source abstract
-
- A Trans-Feminine Youth with a BRCA1 Mutation: Case Study.
- Wolf-Gould CS, Riley MR, Carswell JM.
- LGBT Health. 2018 May/Jun;5(4):270-272. doi: 10.1089/lgbt.2017.0148. Epub 2018 May 11.
- PMID: 29750596
- PubMed abstract
- Source abstract
-
- A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation.
- Scherr CL, Feuston JL, Nixon DM, Cohen SA.
- J Genet Couns. 2018 Apr;27(2):439-445. doi: 10.1007/s10897-018-0222-z. Epub 2018 Feb 8.
- PMID: 29423568
- PubMed abstract
- Source abstract
-
- An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.
- Cohen SA, Scherr CL, Nixon DM.
- J Genet Couns. 2018 Apr;27(2):446-456. doi: 10.1007/s10897-018-0224-x. Epub 2018 Feb 10.
- PMID: 29429041
- PubMed abstract
- Source abstract
-
- Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
- Yamauchi H, Nakagawa C, Kobayashi M, Kobayashi Y, Mano T, Nakamura S, Arai M.
- Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
- PMID: 29019095
- PubMed abstract
- Source abstract
-
- A15 Blood cadmium (Cd) level as a marker of cancer risk in BRCA1 (+) prospective cohort study.
- Marciniak W, Derkacz R, Baszuk P, Kuświk M, Kaczmarek K, Muszyńska M, Lener M, Huzarski T, Gronwald J, Oszurek O, Tołoczko-Grabarek A, Cybulski C, Dębniak T, Morawski A, Jakubowska A, Lubiński J.
- Hered Cancer Clin Pract. 2018 Feb 28;16(Suppl 1):A15. Meeting abstracts from Clinical Genetics of Cancer 2017; Szczecin, Poland. 21-22 September 2017. doi: 10.1186/s13053-018-0087-z.
-
- A16 Arsenic as a marker of cancer risk.
- Derkacz R, Marciniak W, Baszuk P, Kuświk M, Kaczmarek K, Muszyńska M, Lener M, Huzarski T, Gronwald J, Oszurek O, Tołoczko-Grabarek A, Cybulski C, Dębniak T, Morawski A, Jakubowska A, Lubiński J.
- Hered Cancer Clin Pract. 2018 Feb 28;16(Suppl 1):A16. Meeting abstracts from Clinical Genetics of Cancer 2017; Szczecin, Poland. 21-22 September 2017. doi: 10.1186/s13053-018-0087-z.
-
- A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting.
- O'Leary MP, Goldner BS, Abboy S, Mercado PD, Plurad HY.
- Fam Cancer. 2018 Jan;17(1):175-178. doi: 10.1007/s10689-017-0010-1.
- PMID: 28600699
- PubMed abstract
- Source abstract
-
- Prophylaxis of hereditary breast cancer.
- de Groot JS, van Diest PJ, Derksen PWB.
- Aging (Albany NY). 2017 Dec 8;9(12):2453-2454. doi: 10.18632/aging.101342.
- PMID: 29227964
- PubMed abstract
- Editorial
- Free PMC article
- Free Full Text
-
- Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Müllerian Hormone Receptor II.
- Mazumder S, Johnson JM, Swank V, Dvorina N, Martelli E, Ko J, Tuohy VK.
- Cancer Prev Res (Phila). 2017 Nov;10(11):612-624. doi: 10.1158/1940-6207.CAPR-17-0154.
- PMID: 29093011
- PubMed abstract
- Source abstract
Editorial:
Targeting "Retired Antigens" for Cancer Immunoprevention.
- PMID: 29093010
- PubMed abstract
- Source abstract
-
- [Entitlement to prophylactic treatment in cases of genetic predisposition for breast cancer : Interdisciplinary perspectives].
- Meier F, Ried J, Harney A, Rhiem K, Neusser S, Neumann A, Wasem J, Schmutzler R, Huster S, Dabrock P.
- Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Oct;60(10):1102-1108. doi: 10.1007/s00103-017-2608-8.
- PMID: 28795204
- PubMed abstract
- Source abstract
-
- Hereditary gynaecologic cancers in Nepal: a proposed model of care to serve high risk populations in developing countries.
- Pokharel HP, Hacker NF, Andrews L.
- Hered Cancer Clin Pract. 2017 Sep 18;15:12. doi: 10.1186/s13053-017-0072-y. eCollection 2017.
- PMID: 28936272
- PubMed abstract
-
- ['Healthy sick' or: How Genetic Risks Lever the Disease Concept of the Healthcare System].
- Meier F, Ried J, Braun M, Dabrock P.
- Gesundheitswesen. 2017 Aug;79(8-09):594-598. doi: 10.1055/s-0043-109862. Epub 2017 Jul 14.
- PMID: 28709175
- PubMed abstract
- Source abstract
-
- Genetic testing and counseling of a recipient after bone marrow transplant from a sibling harboring a germline BRCA1 pathogenic mutation.
- Škerl P, Krajc M, Blatnik A, Novaković S.
- Oncol Rep. 2017 Jul;38(1):279-282. doi: 10.3892/or.2017.5703. Epub 2017 Jun 6.
- PMID: 28586023
- PubMed abstract
- Source abstract
-
- "The Absence Doubled?" Photo-Poetic Narratives of Prophylactic Mastectomy.
- Bolaki S.
- Lit Med. [2017 Spring;]35(1):1-26. doi: 10.1353/lm.2017.0000.
- PMID: 28529228
- PubMed abstract
- Source abstract
-
- Male transgender breast cancer patient shares his experience in NYT piece.
- Lisa Rezende, Julie Huynh
- FORCE. XRAYS. 2016 Dec 21.
- News
- Free article
-
- Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers.
- Larouche G, Chiquette J, Plante M, Pelletier S, Simard J, Dorval M.
- Can Assoc Radiol J. 2016 Nov;67(4):308-312. doi: 10.1016/j.carj.2015.12.003. Epub 2016 Jun 16.
- PMID: 27318890
- PubMed abstract
- Source abstract
-
- A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.
- Yerushalmi R, Rizel S, Zoref D, Sharon E, Eitan R, Sabah G, Grubstein A, Rafson Y, Cohen M, Magen A, Birenboim I, Margel D, Ozlavo R, Sulkes A, Brenner B, Perry S.
- Isr Med Assoc J. 2016 Sep;18(9):549-552.
- PMID: 28471604
- PubMed abstract
- Source abstract
Editorial:
Handling Individuals with High Cancer Risk: One Size Doesn't Fit All.
- PMID: 28471608
- PubMed abstract
- Source abstract
-
- [Multidisciplinary team meetings settings on the management of women at high risk of inherited breast cancer. A French study].
- Gillmann F, Cordier C, Taris N, Mathelin C, Maugard CM.
- Bull Cancer. 2016 Jun;103(6):571-83. doi: 10.1016/j.bulcan.2016.03.006. Epub 2016 May 11.
- PMID: 27178881
- PubMed abstract
- Source abstract
-
- Addressing inherited predisposition for breast cancer in transplant recipients.
- Yang RL, Kurian AW, Winton LM, Weill D, Patel K, Kingham K, Wapnir IL.
- J Surg Oncol. 2016 May;113(6):605-8. doi: 10.1002/jso.24193. Epub 2016 Feb 10.
- PMID: 26861253
- PubMed abstract
- Source abstract
-
- The Management of Breast Cancer Detected by Reduction Mammaplasty.
- Carlson GW.
- Clin Plast Surg. 2016 Apr;43(2):341-7. doi: 10.1016/j.cps.2015.12.001. Epub 2016 Jan 26.
- PMID: 27012792
- PubMed abstract
- Source abstract
-
- Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
- Gronwald J, Glass K, Rosen B, Karlan B, Tung N, Neuhausen SL, Moller P, Ainsworth P, Sun P, Narod SA, Lubinski J, Kotsopoulos J; Hereditary Breast Cancer Clinical Study Group.
- Fertil Steril. 2016 Mar;105(3):781-5. doi: 10.1016/j.fertnstert.2015.11.034. Epub 2015 Dec 14.
- PMID: 26698676
- PubMed abstract
- Source abstract
-
- Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium.
- Nakamura S, Kwong A, Kim SW, Iau P, Patmasiriwat P, Dofitas R, Aryandono T, Hu Z, Huang CS, Ginsburg O, Rashid MU, Sarin R, Teo SH.
- Public Health Genomics. [2016 Jan;]19(1):53-60. doi: 10.1159/000441714. Epub 2015 Nov 18.
- PMID: 26575363
- PubMed abstract
- Source abstract
-
- The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment.
- Basse C, Arock M.
- Int J Cancer. 2015 Dec 15;137(12):2785-94. doi: 10.1002/ijc.29347. Epub 2014 Dec 1.
- PMID: 25410431
- PubMed abstract
- Source abstract
-
- Hereditary Cancer, Insurance, and Your Legal Rights.
- Anya Prince.
- FORCE. Be Empowered Webinars. 2015 Nov 18.
- Webinar
- Free video
-
- Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.
- Howe R, Miron-Shatz T, Hanoch Y, Omer ZB, O'Donoghue C, Ozanne EM.
- J Genet Couns. 2015 Oct;24(5):744-51. doi: 10.1007/s10897-014-9803-7. Epub 2014 Dec 18.
- PMID: 25519004
- PubMed abstract
- Source abstract
-
- Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge.
- Dupont SC, Boughey JC, Jimenez RE, Hoskin TL, Hieken TJ.
- Surgery. 2015 Oct;158(4):988-95. doi: 10.1016/j.surg.2015.05.020. Epub 2015 Aug 1.
- PMID: 26243343
- PubMed abstract
- Source abstract
-
- BRCA1 and BRCA2 mutations and the risk for colorectal cancer.
- Sopik V, Phelan C, Cybulski C, Narod SA.
- Clin Genet. 2015 May;87(5):411-8. doi: 10.1111/cge.12497. Epub 2014 Oct 21.
- PMID: 25195694
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: article request
Comment / Letter
Is there really an increased risk of early colorectal cancer in women with BRCA1 pathogenic mutations?
- PMID: 26566797
- PubMed abstract
- Source abstract
Reply / Letter
Response to Evans et al.
- PMID: 26482838
- PubMed abstract
- Source abstract
-
- Prediction of breast cancer risk based on profiling with common genetic variants.
- Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M.
- J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv036. doi: 10.1093/jnci/djv036. Print 2015 May.
- PMID: 25855707
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: BREVAGenplus- what is it?
Editorial
Breast cancer prevention in the era of precision medicine.
- PMID: 25855708
- PubMed abstract
- Source abstract
Research News
Genetic screening could improve breast cancer prevention, study finds.
- PMID: 25858913
- PubMed abstract
- Source abstract
-
- [Breast and ovarian cancer due to BRCA1&2 hereditary cancer predisposition syndrome and reproduction: Literature review.]
- Jégu M, Der AS, Morcel K, Abadie C, Fritel X, Levêque J.
- J Gynecol Obstet Biol Reprod (Paris). 2015 Jan;44(1):10-17. doi: 10.1016/j.jgyn.2014.10.011. Epub 2014 Nov 18.
- PMID: 25455630
- PubMed abstract
- Source abstract
-
- Breast Cancer in Male-to-Female Transsexuals: Use of Breast Imaging for Detection.
- Maglione KD, Margolies L, Jaffer S, Szabo J, Schmidt H, Weltz C, Sonnenblick EB.
- AJR Am J Roentgenol. 2014 Dec;203(6):W735-40. doi: 10.2214/AJR.14.12723.
- PMID: 25415740
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
Comments from NSGC Discussion Forum Cancer SIG
Subject: Cancer risks for transgender patient
-
- Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.
- Garcia C, Lyon L, Littell RD, Powell CB.
- Genet Med. 2014 Dec;16(12):896-902. doi: 10.1038/gim.2014.48. Epub 2014 May 22.
- PMID: 24854227
- PubMed abstract
- Source abstract
-
- Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation.
- Hachem HE, Poulain M, Höher M, Fanchin R, Frydman R, Grynberg M.
- Future Oncol. 2014 Oct;10(12):1907-12. doi: 10.2217/fon.14.82.
- PMID: 25386809
- PubMed abstract
- Source abstract
-
- Hormonal and Surgical Treatment in Trans-Women with BRCA1 Mutations: A Controversial Topic.
- Colebunders B, T'Sjoen G, Weyers S, Monstrey S.
- J Sex Med. 2014 Oct;11(10):2496-9. doi: 10.1111/jsm.12628. Epub 2014 Jul 10.
- PMID: 25042481
- PubMed abstract
- Source abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: Cancer risks for transgender patient
-
- Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
- Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, Azodi M, Zheng W, Chambers SK.
- Cancer Prev Res (Phila). 2014 Sep;7(9):896-905. doi: 10.1158/1940-6207.CAPR-13-0408. Epub 2014 Jun 20.
- PMID: 24950779
- PubMed abstract
- Source abstract
-
- Use of fertility drugs and risk of ovarian cancer.
- Diergaarde B, Kurta ML.
- Curr Opin Obstet Gynecol. 2014 Jun;26(3):125-9. doi: 10.1097/GCO.0000000000000060.
- PMID: 24752005
- PubMed abstract
- Source abstract
- Review
- Free PMC article
-
- Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.
- Tomao F, Lo Russo G, Spinelli GP, Tomao S.
- Curr Opin Obstet Gynecol. 2014 Jun;26(3):130-7. doi: 10.1097/GCO.0000000000000067.
- PMID: 24751999
- PubMed abstract
- Source abstract
-
- Randomized Controlled Trial of “The Work” Meditation-Based Intervention for BRCA1/2 Mutation Carriers.
- Lev-Ari Shahar, Landau Carla, Cohen-Mensfild Jiska, Friedman Eitan.
- Journal of Alternative and Complementary Medicine. May 2014, 20(5): A59-A60; doi:10.1089/acm.2014.5155.abstract. 2014 May 7.
- Conference Abstract
- Free Full Text (PDF)
-
- Establishing a program for individuals at high risk for breast cancer.
- Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B.
- J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.
- PMID: 23833688
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer.
- Engel NJ, Gordon P, Thull DL, Dudley B, Herstine J, Jankowitz RC, Zorn KK.
- Fam Cancer. 2012 Sep;11(3):419-27. doi: 10.1007/s10689-012-9530-x.
- PMID: 22644142
- PubMed abstract
- Source abstract
-
- Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer.
- Rhiem K, Pfeifer K, Schmutzler RK, Kiechle M.
- Geburtshilfe Frauenheilkd. 2012 Sep;72(9):833-839.
- PMID: 26640291
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience.
- Shah C, Berry S, Dekhne N, Lanni T, Lowry H, Vicini F.
- Clin Breast Cancer. 2012 Jun;12(3):215-8. doi: 10.1016/j.clbc.2012.03.002. Epub 2012 Apr 14.
- PMID: 22503234
- PubMed abstract
- Source abstract